I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| plasmacytoid dendritic cell | 12 studies | 30% ± 10% | |
| basal cell | 10 studies | 26% ± 10% | |
| epithelial cell | 9 studies | 42% ± 18% | |
| connective tissue cell | 8 studies | 28% ± 12% | |
| epithelial cell of proximal tubule | 7 studies | 29% ± 9% | |
| fibroblast | 7 studies | 25% ± 8% | |
| myofibroblast cell | 6 studies | 23% ± 8% | |
| pericyte | 6 studies | 23% ± 5% | |
| CD8-positive, alpha-beta T cell | 6 studies | 25% ± 8% | |
| conventional dendritic cell | 5 studies | 27% ± 12% | |
| progenitor cell | 5 studies | 34% ± 11% | |
| smooth muscle cell | 5 studies | 23% ± 5% | |
| hematopoietic stem cell | 5 studies | 28% ± 6% | |
| abnormal cell | 5 studies | 25% ± 8% | |
| hematopoietic precursor cell | 4 studies | 36% ± 10% | |
| plasma cell | 4 studies | 34% ± 13% | |
| plasmablast | 4 studies | 48% ± 16% | |
| goblet cell | 4 studies | 24% ± 8% | |
| intestinal crypt stem cell | 4 studies | 28% ± 4% | |
| mesothelial cell | 4 studies | 41% ± 10% | |
| B cell | 4 studies | 22% ± 5% | |
| transit amplifying cell | 4 studies | 23% ± 3% | |
| erythroblast | 4 studies | 33% ± 10% | |
| endothelial cell | 4 studies | 21% ± 6% | |
| macrophage | 4 studies | 22% ± 7% | |
| CD4-positive, alpha-beta T cell | 4 studies | 33% ± 11% | |
| precursor cell | 3 studies | 43% ± 11% | |
| classical monocyte | 3 studies | 19% ± 3% | |
| non-classical monocyte | 3 studies | 26% ± 5% | |
| enteroendocrine cell | 3 studies | 31% ± 10% | |
| neural crest cell | 3 studies | 27% ± 7% | |
| common myeloid progenitor | 3 studies | 33% ± 14% | |
| ciliated cell | 3 studies | 24% ± 5% | |
| dendritic cell | 3 studies | 46% ± 6% | |
| granulocyte monocyte progenitor cell | 3 studies | 34% ± 12% | |
| natural killer cell | 3 studies | 22% ± 5% |
